International cooperative study identifies treatment strategy in childhood ambiguous lineage leukemia
Ondřej Hrušák(Charles University), Válerie de Haas(Stichting Kinderoncologie Nederland), Jitka Stančíková(Charles University), Barbora Vakrmanová(Charles University), Iveta Janotová(Charles University), Ester Mejstříková(Charles University), Václav Čapek(Charles University), Jan Trka(Charles University), Markéta Žaliová(Charles University), Aleš Lukš(Charles University), Kirsten Bleckmann(Christian-Albrechts-Universität zu Kiel), Anja Möricke(Christian-Albrechts-Universität zu Kiel), Julie Irving(Newcastle University), Benigna Konatkowska(Poznan University of Medical Sciences), Thomas Alexander(St. Jude Children's Research Hospital), Hiroto Inaba(St. Jude Children's Research Hospital), Kjeld Schmiegelow(University of Copenhagen), Simone Stokley(Nottingham University Hospitals NHS Trust), Zuzana Zemanová(Charles University), Anthony V. Moorman(Newcastle University), Jorge G. Rossi(Center for Rheumatology), Marı́a Sara Felice(Garrahan Hospital), Luciano Dalla‐Pozza(Sydney Children’s Hospitals Network), Jessa Morales(Sydney Children’s Hospitals Network), Michael Dworzak(St Anna Children's Hospital), Barbara Buldini(University of Padua), Giuseppe Basso(University of Padua), Myriam Campbell(Hospital Roberto del Rio), María Elena Cabrera(Hospital Roberto del Rio), Neda Marinov(Hospital Roberto del Rio), Sarah Elitzur(Schneider Children's Medical Center), Shai Izraeli(Tel Aviv University), Drorit Luria(Schneider Children's Medical Center), Tamar Feuerstein(Schneider Children's Medical Center), Alexandra Kolenová(Comenius University Bratislava), Peter Švec(Comenius University Bratislava), Olena Kreminska, Karen R. Rabin(Baylor College of Medicine), Sophia Polychronopoulou(Children's Hospital Agia Sophia), Elaine Sobral da Costa(Universidade Federal do Rio de Janeiro), Hanne Vibeke Marquart(University of Copenhagen), Antonis Kattamis(National and Kapodistrian University of Athens), Richard Ratei(Helios Hospital Berlin-Buch), Dirk Reinhardt(Essen University Hospital), John Choi(St. Jude Children's Research Hospital), Martin Schrappe(Christian-Albrechts-Universität zu Kiel), Jan Starý(Charles University)
Cited by 108Open Access
Abstract
and no other lymphoid features. No overall benefit of transplantation was documented, and it could be introduced in some patients with a poor response to treatment. As no clear indicator was found for a change in treatment type, this is to be considered only in cases with ≥5% blasts after remission induction. The results provide a basis for a prospective trial.
Related Papers
No related papers found
Powered by citation graph analysis